WO2004011604A3 - Nucleic acid-associated proteins - Google Patents

Nucleic acid-associated proteins Download PDF

Info

Publication number
WO2004011604A3
WO2004011604A3 PCT/US2003/023245 US0323245W WO2004011604A3 WO 2004011604 A3 WO2004011604 A3 WO 2004011604A3 US 0323245 W US0323245 W US 0323245W WO 2004011604 A3 WO2004011604 A3 WO 2004011604A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
naap
associated proteins
polynucleotides
agonists
Prior art date
Application number
PCT/US2003/023245
Other languages
French (fr)
Other versions
WO2004011604A2 (en
Inventor
Patricia M Mason
Anita Swarnakar
Xin Jiang
Alan A Jackson
Amy E Kable
Original Assignee
Incyte Corp
Patricia M Mason
Anita Swarnakar
Xin Jiang
Alan A Jackson
Amy E Kable
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp, Patricia M Mason, Anita Swarnakar, Xin Jiang, Alan A Jackson, Amy E Kable filed Critical Incyte Corp
Priority to AU2003269922A priority Critical patent/AU2003269922A1/en
Publication of WO2004011604A2 publication Critical patent/WO2004011604A2/en
Publication of WO2004011604A3 publication Critical patent/WO2004011604A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Abstract

Various embodiments of the invention provide human nucleic acid-associated proteins (NAAP) and polynucleotides which identify and encode NAAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of NAAP.
PCT/US2003/023245 2002-07-26 2003-07-23 Nucleic acid-associated proteins WO2004011604A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003269922A AU2003269922A1 (en) 2002-07-26 2003-07-23 Nucleic acid-associated proteins

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US39890702P 2002-07-26 2002-07-26
US60/398,907 2002-07-26
US40706802P 2002-08-30 2002-08-30
US60/407,068 2002-08-30
US41413902P 2002-09-26 2002-09-26
US60/414,139 2002-09-26
US42409402P 2002-11-05 2002-11-05
US60/424,094 2002-11-05
US44091203P 2003-01-17 2003-01-17
US60/440,912 2003-01-17
US44241903P 2003-01-24 2003-01-24
US60/442,419 2003-01-24

Publications (2)

Publication Number Publication Date
WO2004011604A2 WO2004011604A2 (en) 2004-02-05
WO2004011604A3 true WO2004011604A3 (en) 2005-12-22

Family

ID=31192536

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/023245 WO2004011604A2 (en) 2002-07-26 2003-07-23 Nucleic acid-associated proteins

Country Status (2)

Country Link
AU (1) AU2003269922A1 (en)
WO (1) WO2004011604A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9322009B2 (en) 2010-06-01 2016-04-26 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Lysyl-tRNA synthetases

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2534567A1 (en) 2003-08-18 2005-03-03 Wyeth Novel human lxr alpha variants

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001079254A1 (en) * 2000-04-18 2001-10-25 Hyseq, Inc. Novel nucleic acids and polypeptides
US20020132753A1 (en) * 2000-01-31 2002-09-19 Rosen Craig A. Nucleic acids, proteins, and antibodies

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020132753A1 (en) * 2000-01-31 2002-09-19 Rosen Craig A. Nucleic acids, proteins, and antibodies
WO2001079254A1 (en) * 2000-04-18 2001-10-25 Hyseq, Inc. Novel nucleic acids and polypeptides

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9322009B2 (en) 2010-06-01 2016-04-26 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Lysyl-tRNA synthetases

Also Published As

Publication number Publication date
AU2003269922A1 (en) 2004-02-16
WO2004011604A2 (en) 2004-02-05

Similar Documents

Publication Publication Date Title
WO2004087875A3 (en) Nucleic acid-associated proteins
WO2003052075A3 (en) Enzymes
WO2002063005A3 (en) Lipid-associated molecules
WO2003094848A3 (en) Nucleic acid-associated proteins
WO2003042357A3 (en) Enzymes
WO2002097060A3 (en) Carbohydrate-associated proteins
WO2003076586A3 (en) Nucleic acid-associated proteins
WO2004044165A3 (en) Lipid-associated proteins
WO2003054219A3 (en) Nucleic acid-associated proteins
WO2003062391A3 (en) Structural and cytoskeleton-associated proteins
WO2003038052A3 (en) Nucleic acid-associated proteins
WO2003010329A3 (en) Nucleic acid-associated proteins
WO2002066646A3 (en) Neurotransmission-associated proteins
WO2004003162A3 (en) Enzymes
WO2001083524A3 (en) Rna metabolism proteins
WO2002099115A3 (en) Nucleic acid-associated proteins
WO2003016549A3 (en) Nucleic-acid associated proteins
WO2003072729A3 (en) Enzymes
WO2003006618A3 (en) Nucleic acid-associated proteins
WO2003093439A3 (en) Enzymes
WO2003083082A3 (en) Enzymes
WO2004011604A3 (en) Nucleic acid-associated proteins
WO2004022705A3 (en) Neurotransmission-associated proteins
WO2003000864A8 (en) Nucleic acid-associated proteins
WO2002079389A3 (en) Nucleic acid-associated proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP